2-(3-Methoxyphenyl)-7-methylimidazo[1,2-a]pyridine-3-carbaldehyde

Catalog No. :
ACUERF587
CAS No. :
727652-04-2
Molecular Formula :
C16H14N2O2
Molecular Weight :
266.30

IUPAC Name:2-(3-methoxyphenyl)-7-methylimidazo[1,2-a]pyridine-3-carbaldehyde

2-(3-Methoxyphenyl)-7-methylimidazo[1,2-a]pyridine-3-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$209.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-Methoxyphenyl)-7-methylimidazo[1,2-a]pyridine-3-carbaldehyde
IUPAC Name2-(3-methoxyphenyl)-7-methylimidazo[1,2-a]pyridine-3-carbaldehyde
MDL No.MFCD04117013
Molecular FormulaC16H14N2O2
Molecular Weight266.30
SMILESO=CC1=C(C2=CC=CC(OC)=C2)N=C3C=C(C)C=CN31
InChI KeyMZBCCRDBXSINSQ-UHFFFAOYSA-N
Synonym2-(3-METHOXY-PHENYL)-7-METHYL-IMIDAZO[1,2-A]-PYRIDINE-3-CARBALDEHYDE;2-(3-methoxyphenyl)-7-methyl-3-imidazo[3,2-a]pyridinecarboxaldehyde;2-(3-methoxyphenyl)-7-methyl-imidazo[3,2-a]pyridine-3-carbaldehyde;2-(3-methoxyphenyl)-7-methylimidazo[3,2-a]pyridine-3-carbaldehyde;ZINC01527457;Imidazo[1,2-a]pyridine-3-carboxaldehyde, 2-(3-methoxyphenyl)-7-methyl-
CAS No.727652-04-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACUERF587 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUERF587 route product structure diagram
    ACUERF587727652-04-2
Inquiry

2. ACUERF587 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUERF587 route product structure diagram
    ACUERF587727652-04-2
Inquiry

Comments (0)